Variant · Deletion
BRAF Asn486_Pro490del
CI-VAR-00000261Explore in graph →NM_004333.6:c.1457_1471del15CIViC 5486
Curated evidence
Evidence by cancer (2 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
- Source
- CIViC — Clinical Interpretation of Variants in Cancer
- Dataset
- CIViC evidence items
- Version
- civic-2026-09-08
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- expert curation
- License
- CC0 1.0
- PMID
- 26732095
- Run
- ING-CIVIC-20260908-000001
| Molecular profile | Therapy | Type | Level | Direction · significance | Rating (1–5) | Status | Evidence | Source |
|---|---|---|---|---|---|---|---|---|
| Malignant Neoplasm1 | ||||||||
| BRAF Asn486_Pro490del | (oncogenic) | Oncogenic | D | Supports Oncogenicity | 5 | submitted | EID12993BRAF p.Asn486_Pro490del (NM_004333.6:c.1457_1471del15) causes increased colony formation (triplicates). Class 2 BRAF variant. PMID 26732095 · Chen et al., 2016 · Open in CIViC | civic |
| Unmapped disease1unmapped disease | ||||||||
| BRAF Asn486_Pro490del | (functional) | Functional | D | Supports Gain Of Function | 5 | submitted | EID12994BRAF p.Asn486_Pro490del (NM_004333.6:c.1457_1471del15) causes increased ratio of pERK/ERK. Class 2 BRAF variant. PMID 26732095 · Chen et al., 2016 · Open in CIViC | civic |
ClinVar
Clinical significance (0)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
Data not yet available